National Institute of Mental Health; Notice of Closed Meetings

---
identifier: "/us/fr/2022-21263"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute of Mental Health; Notice of Closed Meetings"
title_number: 0
title_name: "Federal Register"
section_number: "2022-21263"
section_name: "National Institute of Mental Health; Notice of Closed Meetings"
positive_law: false
currency: "2022-09-30"
last_updated: "2022-09-30"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2022-21263"
document_type: "notice"
publication_date: "2022-09-30"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "87 FR 59446"
fr_volume: 87
---


#  National Institute of Mental Health; Notice of Closed Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:* National Institute of Mental Health Special Emphasis Panel; Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (P50).

*Date:* October 25, 2022.

*Time:* 11:00 a.m. to 4:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).

*Contact Person:* Serena Chu, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health Neuroscience Center, 6001 Executive Blvd., Room 6000, MSC 9606, Bethesda, MD 20852, 301-500-5829, *[email protected]* .

*Name of Committee:* National Institute of Mental Health Special Emphasis Panel; Early-Stage Clinical Trials of Pharmacologic or Device-Based Interventions.

*Date:* October 26, 2022.

*Time:* 12:30 p.m. to 5:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).

*Contact Person:* Marcy Ellen Burstein, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, Neuroscience Center, 6001 Executive Blvd., Room 6143, MSC 9606, Bethesda, MD 20892-9606 301-443-9699 *[email protected]* .

(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS)

Dated: September 26, 2022.

Miguelina Perez,

Program Analyst, Office of Federal Advisory Committee Policy.